Home > Oceania > Australia > Australia Patient

This website is intended for Australian patients prescribed Lagevrio® (molnupiravir) and their carers.

PRESCRIPTION ONLY MEDICINE
KEEP OUT OF REACH OF CHILDREN
Each capsule contains 200 mg molnupiravir
Each bottle contains 40 capsules
AUST R 372650
Store below 30ºC


If you have any questions about your condition or the medicine you have been prescribed, please talk to your doctor or pharmacist.


Have a question about an MSD Product or want to report an Adverse Event or Quality Issue?

Phone: 1800 818 553
Monday – Friday 9:30 a.m. – 5:30 p.m. AEDT


MSD Australia Head Office

Phone: +61 2 8988 8000
Monday – Friday 8:30 a.m. – 5:30 p.m. AEDT
Level 1 – Building A, 26 Talavera Road
Macquarie Park, NSW 2113
AUSTRALIA

PBS information: LAGEVRIO® is listed on the PBS – Authority Required (STREAMLINED). Please refer to www.pbs.gov.au for eligibility criteria.


Copyright © 2023 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.

AU-ANV-00014. Issued December 2023.